World Swine Vaccine Market Driven by PCV2 Vaccination

The global swine industry increasingly relies on vaccination, according to Boehringer Ingelheim. With a total market value of €525 million in 2008, vaccines have become the most important health management tool for modern pig production (Vetnosis Ltd, March 2009).

The driver of this growth are vaccines against Porcine Circovirus Type 2 (PCV2), which have quickly become a standard vaccination in all major markets, alongside Mycoplasma vaccination programmes. The size of the PCV2-vaccine market is close to €180 million.

With total sales of ”€90 million, Boehringer's Ingelvac CircoFLEX was the global market leader in this segment last year (Animal Pharm, April 2009 and Boehringer Ingelheim).

Sign up for our
regular news updates

Related news items:

•    Third TOPIGS Import into China in Three Months
•    OleoServ Takes over Harles & Jentzsch Assets
•    Nutreco Achieves Excellent Progress in 2011
•    New Zealand Pork Seeks New CEO
•    Two Cases of ASF in Wild Boar

Related News Categories: Pig Health, Company/Products

Sign up for our
regular news updates

More of the latest Pig Industry News

•   CME: Changes for Beef, Pork & Poultry Supplies
•   Action Taken to Ramp Up Abattoir Inspections
•   FAO Food Price Index Rebounds in January
•   US Pork Export Forecast is Unchanged
•   Public Resistance Ousts GM Crops From EU
•   Animal Welfare: The Right Thing to Do
•   2011 Pork Imports Higher Than a Year Ago
•   New Way to Map Drought and Water Use
•   Nutreco CEO to Step Down at End of 2012
•   Importers Face High Stocks & Weak Demand